Filing Details
- Accession Number:
- 0001209191-21-067647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-02 17:08:05
- Reporting Period:
- 2021-11-30
- Accepted Time:
- 2021-12-02 17:08:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1566044 | Vyne Therapeutics Inc. | VYNE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1055404 | G Patrick Lepore | 520 U.s. Highway 22, Suite 204 Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-30 | 12,500 | $1.02 | 62,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares were purchased pursuant to a 10b5-1 plan entered into by the reporting person on April 21, 2021.
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.98 to $1.03, inclusive. The reporting person undertakes to provide to VYNE Therapeutics Inc., any security holder of VYNE Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
